International Business News - Pozen http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Pozen Inc said U.S. health regulators have accepted a marketing application for its experimental pain drug Vimovo, triggering a $10 million milestone payment from AstraZeneca to Pozen. http://www.ibtimes.com/articles/20090831/update-pozen-says-us-fda-accepts-vimovo-marketing-application.htm Mon, 31 Aug 2009 10:43:53 EDT